Financials bioMérieux

Equities

Market Closed - Euronext Paris Other stock markets 16:55:00 16/07/2025 BST			5-day change	1st Jan Change
118.30 ^EUR	0.00%		-0.59%	+14.30%

07-15	AlphaValue/Baader Europe Ups BioMérieux Price Target	MT
07-14	BIOMÉRIEUX : AlphaValue raises target price

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	3,118	3,376	3,589	3,675	3,980	4,261	4,575	4,918
Change	-	8.27%	6.31%	2.39%	8.3%	7.06%	7.38%	7.5%
EBITDA ¹	823.5	1,032	864.2	827	913.9	1,003	1,104	1,244
Change	-	25.34%	-16.28%	-4.3%	10.51%	9.72%	10.07%	12.72%
EBIT ¹	595.1	784.3	587.2	439	614.7	693.5	772.8	870.7
Change	-	31.79%	-25.13%	-25.24%	40.02%	12.82%	11.43%	12.66%
Interest Paid ¹	-28.5	-9.8	-6.6	-1.7	-9.4	-6.033	-5.7	-4.9
Earnings before Tax (EBT) ¹	524.1	773.8	580.6	437.3	579.4	658.8	728.6	850.9
Change	-	47.64%	-24.97%	-24.68%	32.49%	13.71%	10.6%	16.78%
Net income ¹	404.4	601.1	452.4	358	432	524.3	580.9	657.2
Change	-	48.64%	-24.74%	-20.87%	20.67%	21.37%	10.78%	13.15%
Announcement Date	24/02/21	02/03/22	07/03/23	14/03/24	07/03/25	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q4	2022 Q2	2022 Q3	2022 Q4	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2025 Q1	2025 Q2	2025 Q3	2025 Q4
Net sales ¹	768.8	707	789.4	852.6	844.6	729.6	924.2	820.9	902	1,029	864.3	898.4	1,006	965.2	936.7	968.7	1,098	981	1,030	1,159
Change	-	-8.04%	11.65%	8.01%	-0.94%	-13.62%	26.67%	-11.18%	9.88%	14.09%	-16.01%	3.95%	12%	-4.07%	-2.95%	3.42%	13.34%	-10.65%	4.99%	12.52%
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Charge d'intérêts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Announcement Date	16/04/20	02/09/20	22/10/20	24/02/21	01/06/21	01/09/21	02/03/22	31/08/22	26/10/22	07/03/23	31/08/23	26/10/23	14/03/24	09/04/24	05/09/24	30/10/24	-	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2020 S2	2021 S1	2021 S2	2022 S1	2022 S2	2023 S1	2023 S2	2024 S1	2024 S2	2025 S1	2025 S2
Net sales ¹	1,642	1,574	-	1,658	1,931	1,770	-	1,902	2,078	2,079	2,189
Change	-	-4.13%	-	-	16.47%	-8.34%	-	-	9.26%	0.05%	5.29%
EBITDA ¹	-	-	-	-	-	-	-	424.3	489.6	477	511
Change	-	-	-	-	-	-	-	-	15.39%	-2.57%	7.13%
EBIT	351	365.8	-	297.1	290.1	207.8	231.2	306	326.4	-	-
Change	-	4.22%	-	-	-2.36%	-28.37%	11.26%	32.35%	6.67%	-	-
Charge d'intérêts ¹	-16.1	-6.4	-3.4	-5.6	-1	-	-	-4.8	-	-1	-1
Earnings before Tax (EBT) ¹	304.7	358.5	-	-	289.1	-	-	-	295.9	324	341
Change	-	17.66%	-	-	-	-	-	-	-	9.5%	5.25%
Net income ¹	231.5	277.1	-	228	224.4	-	-	-	-	250	263
Change	-	19.7%	-	-	-1.58%	-	-	-	-	-	5.2%
Announcement Date	24/02/21	01/09/21	02/03/22	31/08/22	07/03/23	31/08/23	14/03/24	05/09/24	07/03/25	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	92.1	-341	-47	166	40.9	-280	-583	-925
Change	-	-470.25%	86.22%	453.19%	-75.36%	-784.6%	-108.21%	-58.66%
Announcement Date	24/02/21	02/03/22	07/03/23	14/03/24	07/03/25	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	277.5	290.1	286.7	338.3	345.8	404.4	419	449.7
Change	-	4.54%	-1.17%	18%	2.22%	16.94%	3.6%	7.34%
Free Cash Flow (FCF) ¹	305.3	521	195.3	115.3	329.7	486	496.2	595.5
Change	-	70.65%	-62.51%	-40.96%	185.95%	47.4%	2.1%	20.02%
Announcement Date	24/02/21	02/03/22	07/03/23	14/03/24	07/03/25	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	26.41%	30.57%	24.08%	22.5%	22.96%	23.53%	24.13%	25.3%
EBIT Margin (%)	19.08%	23.23%	16.36%	11.95%	15.45%	16.28%	16.89%	17.7%
EBT Margin (%)	16.81%	22.92%	16.18%	11.9%	14.56%	15.46%	15.93%	17.3%
Net margin (%)	12.97%	17.8%	12.6%	9.74%	10.85%	12.31%	12.7%	13.36%
FCF margin (%)	9.79%	15.43%	5.44%	3.14%	8.28%	11.41%	10.85%	12.11%
FCF / Net Income (%)	75.49%	86.67%	43.17%	32.21%	76.32%	92.69%	85.42%	90.61%
Profitability
ROA	10.49%	14.07%	9.24%	6.85%	7.83%	8.81%	8.95%	9.62%
ROE	17.45%	21.64%	13.47%	9.73%	10.86%	11.94%	12.08%	12.51%
Financial Health
Leverage (Debt/EBITDA)	0.11x	-	-	0.2x	0.04x	-	-	-
Debt / Free cash flow	0.3x	-	-	1.44x	0.12x	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	8.9%	8.59%	7.99%	9.21%	8.69%	9.49%	9.16%	9.14%
CAPEX / EBITDA (%)	33.7%	28.11%	33.18%	40.91%	37.84%	40.33%	37.96%	36.15%
CAPEX / FCF (%)	90.89%	55.68%	146.8%	293.41%	104.88%	83.21%	84.44%	75.52%
Items per share
Cash flow per share ¹	4.914	6.85	4.012	3.745	5.62	7.2	7.457	8.723
Change	-	39.39%	-41.44%	-6.65%	50.07%	28.12%	3.57%	16.97%
Dividend per Share ¹	0.62	0.85	0.85	0.85	0.9	1.015	1.133	1.296
Change	-	37.1%	0%	0%	5.88%	12.78%	11.63%	14.39%
Book Value Per Share ¹	20.54	26.3	-	31.55	35.41	38.82	42.6	46.92
Change	-	28.04%	-	-	12.25%	9.61%	9.74%	10.15%
EPS ¹	3.41	5.06	3.82	3.01	3.64	4.447	4.945	5.615
Change	-	48.39%	-24.51%	-21.2%	20.93%	22.17%	11.19%	13.55%
Nbr of stocks (in thousands)	118,316	118,336	118,374	118,124	118,006	117,932	117,932	117,932
Announcement Date	24/02/21	02/03/22	07/03/23	14/03/24	07/03/25	-	-	-